Edition:
United States

Insider Trading: Osiris Therapeutics Inc (OSIR.OQ)

OSIR.OQ on NASDAQ Stock Exchange Global Market

5.68USD
2 Dec 2016
Change (% chg)

$0.06 (+1.07%)
Prev Close
$5.62
Open
$5.68
Day's High
$5.82
Day's Low
$5.54
Volume
26,282
Avg. Vol
24,921
52-wk High
$10.97
52-wk Low
$3.55

All Insider Trades
Trading Date Name Title Type Shares Traded Price
19 Nov 2015

Debrabandere (Lode)

Chief Executive Officer Buy 37,500 $6.84
18 Nov 2015

Danilkovitch (Alla)

Officer Buy 4,000 $5.08
9 Aug 2015

Danilkovitch (Alla)

Officer Buy 5,000 $0.40
9 Aug 2015

Danilkovitch (Alla)

Officer Sell 2,425 $18.22
3 Jun 2015

Law (Gregory Ivan)

Officer Buy 100 $18.83
26 May 2015

Jacoby (Philip R Jr)

Chief Financial Officer Buy 4,860 $7.13
26 May 2015

Jacoby (Philip R Jr)

Chief Financial Officer Buy 3,751 $6.46
26 May 2015

Jacoby (Philip R Jr)

Chief Financial Officer Buy 11,389 $7.74
26 May 2015

Jacoby (Philip R Jr)

Chief Financial Officer Sell 20,000 $18.55

Institutional Holders

% Shares Owned: 35.43%
# of Holders: 100
Total Shares Held: 12,206,925
3 Mo. Net Change: -250,846
# New Positions: 7
# Closed Positions: 10
# Increased Positions: 28
# Reduced Positions: 37
# Net Buyers: -9

Officers & Directors

Name Age Since Current Position

Peter Friedli

62 Chairman of the Board

David Dresner

68 2016 Interim President and Chief Executive Officer

Gregory Law

49 2015 Chief Financial Officer, Corporate Secretary and Treasurer

Frank Czworka

46 2014 Vice President, General Manager of Wound Care

Adrian Mollo

41 2014 General Counsel

R. Alberto Avendano

55 2016 Chief Medical Officer

Alla Danilkovitch

51 2015 Chief Scientific Officer

Thomas Brandt

63 2016 Independent Director

Jay Moyes

62 2006 Independent Director

Aziz Ahmad

IR Contact